Ysios Capital Partners is a private equity and venture capital firm founded in 2008 and headquartered in Donostia‑San Sebastián, Spain, with additional offices in Europe and North America. The firm focuses on seed, early‑stage, and growth financing for companies in human healthcare, life sciences, digital health, biotechnology, pharmaceuticals, diagnostics, medical devices, and e‑health. It typically invests between $1.2 million and $22.7 million, often taking a board seat and providing follow‑on capital. Ysios targets product‑development projects rather than services, and seeks to hold investments for four to six years, exiting through public offerings or mergers and acquisitions. The firm prefers companies located in North America and Europe, with a particular emphasis on Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Liechtenstein, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.